Translate page

VEP MahonThe 2019 Goldman Prize is awarded to Professor François-Xavier Mahon

The iCMLf awards the 2019 Goldman Prize to Professor François-Xavier Mahon, Director of the Cancer Center of Bordeaux (Bergonie Institute) in recognition of his breakthrough achievements in the clinical development of CML therapies and his pioneering research on treatment discontinuation in CML. The annual Goldman Prize awarded in honour of Professor John Goldman, acknowledges outstanding lifetime contributions to the management of patients with CML.

Carolina PavlovskyThe 2019 iCMLf Prize is awarded to Dr Carolina Pavlovsky (Argentina)

The 2019 iCMLf Prize winner is Dr Carolina Pavlovsky, Head of the Research Department at Fundaleu (Foundation to fight Leukemia), in Buenos Aires, Argentina. She has been awarded the prize for her efforts to continually bring the ‘real-world’ perspectives of the emerging economic regions into the scientific discussion of CML management. This prize is awarded by the iCMLf for outstanding contributions to the improvement of CML treatment under the challenging conditions of emerging economic countries with unequal access to monitoring and treatment.

 

Nick CrossThe 2018 iCMLf Rowley Prize is awarded to Professor Nick Cross

‘Nick Cross has been the driving force behind the harmonization of molecular response criteria in CML, especially deep molecular response, a critical step towards making TFR possible and practical. He has also led the discovery and description of BCR-ABL-negative CML-like syndromes.’ (Timothy Hughes, Chairman of the iCMLf)

The 2018 Rowley Prize winner is Nick Cross, Professor of Human Genetics at the University of Southampton (UK). Professor Cross receives the prize in recognition of his scientific achievements to better understand the molecular pathogenesis of chronic myeloid leukemia and the development, validation and standardisation of genetic tests.

Jorge Cortes 2013The 2018 iCMLf Goldman Prize is awarded to Professor Jorge Cortes

'Jorge has led many of the most important CML trials over the past decade and is now regarded as the pre-eminent world expert in CML management. He has also tirelessly disseminated his unique expertise to colleagues at his own centre and around the world.' 
(Timothy Hughes, Chairman of the iCMLf)

Jorge Cortes, Professor of Medicine and Deputy Chair at the Department of Leukemia at the MD Anderson Cancer Center, has been awarded the 2018 iCMLf Goldman Prize. The award celebrates his globally recognised expertise and life-long commitment to the management of patients with CML.

Hemant MalhotraThe 2018 iCMLf Prize is awarded to Hemant Malhotra from India 

'The award recognises Hemant’s remarkable achievements in CML management in a challenging environment and his work to improve outcomes for CML patients.' 
(Timothy Hughes, Chairman of the iCMLf)

The iCMLf Directors and Advisors have selected Dr Hemant Malhotra, Senior Professor at the SMS Medical College Hospital and Head of the Division of Medical Oncology at the RK Birla Cancer Centre in Jaipur (India) as the 2018 iCMLf Prize winner. Dr Malhotra receives the prize in recognition of his tireless efforts and remarkable achievements to advance the treatment of CML patients in India and neighbouring countries.

The 2016 iCMLf Rowley Prize is awarded to Professors Groffen and Heisterkamp

John Groffen

Nora Heisterkamp

In 2016 the iCMLf Directors and a panel of previous prize winners, have named two renowned scientists as the recipients of the 2016 Rowley Prize: Professor John Groffen and Professor Nora Heisterkamp. This prestigious award celebrates the people who have made outstanding lifetime contributions to the understanding of the biology of CML.